GlassScriptPhysician profile
Ashley Thomas-Graham
NPI 1588442495
$1,043.31
in general payments reported to CMS, 2019-2025
15 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.03 · 2024: $344 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.69 | 2023-2025 | |
| Almatica Pharma LLC | $136.50 | 2024-2025 | Loreev Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $92.92 | 2024-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $89.37 | 2024-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $82.86 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $80.14 | 2024-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Lundbeck LLC | $77.71 | 2024-2025 | Abilify Asimtufii, Rexulti |
| Axsome Therapeutics, INC. | $49.96 | 2024-2025 | Auvelity, Sunosi |
| Alkermes, INC. | $44.32 | 2025 | Lybalvi, Aristada |
| E.R. Squibb & Sons, L.L.C. | $39.47 | 2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $36.21 | 2024-2025 | Ingrezza |
| Biogen, INC. | $28.57 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $16.95 | 2025 | Qelbree |
| Idorsia Pharmaceuticals US INC | $16.87 | 2023 | Quviviq |
| Collegium Pharmaceutical, INC. | $16.77 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Thomas-Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.